Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
Front Neurol
.
2022 Aug 30:13:996342.
doi: 10.3389/fneur.2022.996342.
eCollection 2022.
Authors
Aurora Zanghì
1
,
Carlo Avolio
2
3
,
Hans-Peter Hartung
4
5
6
,
Emanuele D'Amico
2
Affiliations
1
Unitá Operativa Complessa (UOC) Neurology, Sant'Elia Hospital, Caltanissetta, Italy.
2
Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
3
Department of Neurosciences, Head of Multiple Sclerosis Center, Policlinico Riuniti Hospital, Foggia, Italy.
4
Department of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
5
Brain and Mind Center, The University of Sydney, Sydney, NSW, Australia.
6
Department of Neurology, Palacky University Olomouc, Olomouc, Czechia.
PMID:
36119682
PMCID:
PMC9481414
DOI:
10.3389/fneur.2022.996342
No abstract available
Keywords:
age; disease modifying therapies; immunosenescence; inflammaging; multiple sclerosis.
Publication types
Editorial